NDC 42291-824
Metformin hydrochlorideER 750 mg tablet, extended release
On the label: AvKARE, Inc.. It's repackaged: AvKARE, Inc. rebottles it from Unichem Pharmaceuticals (USA), Inc.'s NDC 76385-129.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Beximco Pharmaceuticals PLC | Tongi, Bangladesh | Makes it | Problems found, fixed voluntarilyMar 30, 2023 · 2 inspections |
Recalls
- Aug 19, 2020 · Class II · Bayshore Pharmaceuticals
CGMP Deviations
Lots: Lot #18641; Exp. 05/2021 - Aug 19, 2020 · Class II · Bayshore Pharmaceuticals
CGMP Deviations
Lots: Lot #18657, Exp. 05/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Metformin: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 750 mg
- Approval
- ANDA ANDA207427
- On the market since
- Jun 11, 2024
- Package NDCs
42291-824-1042291-824-5042291-824-90- Official label
- DailyMed (National Library of Medicine), updated Nov 4, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?